Data / Form D filings / MedShape, Inc.
MedShape, Inc.: Form D filings
MedShape, Inc., a biotechnology company in Atlanta, GA, filed 11 Form D notices with the SEC between 2009 and 2014. The latest, on August 22, 2014, reports $700,000 sold of a $4 million offering to 2 investors.
Find out what MedShape, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1575 NORTHSIDE DRIVE, NW, SUITE 440, Atlanta, GA, 30318
- Phone
- (404) 249-9155
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Georgia
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1463845
The full lists. Form D filings in Georgia: 1,337 rows, $66.85, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 22, 2014 | Amendment | $4,000,000 | $700,000 | $3,300,000 | 2 | Jul 28, 2014 | sec.gov |
| Aug 7, 2014 | New notice | $4,000,000 | $350,000 | $3,650,000 | 1 | Jul 28, 2014 | sec.gov |
| Feb 27, 2013 | Amendment | $8,000,000 | $6,057,007 | $1,942,993 | 9 | Jun 18, 2012 | sec.gov |
| Aug 15, 2012 | Amendment | $8,000,000 | $2,540,627 | $5,459,373 | 4 | Jun 18, 2012 | sec.gov |
| Jun 29, 2012 | New notice | $8,000,000 | $2,500,019 | $5,499,981 | 3 | Jun 18, 2012 | sec.gov |
| Jul 19, 2011 | Amendment | $7,000,000 | $5,687,751 | $1,312,249 | 18 | Mar 15, 2011 | sec.gov |
| May 12, 2011 | Amendment | $7,000,000 | $190,978 | $6,809,022 | 4 | Mar 15, 2011 | sec.gov |
| Mar 29, 2011 | New notice | $4,200,000 | $124,981 | $4,075,019 | 2 | Mar 15, 2011 | sec.gov |
| Sep 15, 2009 | Amendment | $10,000,000 | $9,785,108 | $214,892 | 24 | May 21, 2009 | sec.gov |
| Aug 7, 2009 | Amendment | $10,000,000 | $3,270,131 | $6,729,869 | 16 | May 21, 2009 | sec.gov |
| Jun 4, 2009 | New notice | $10,000,000 | $150,000 | $9,850,000 | 1 | May 21, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Niles Noblitt | Director | |
| Paul F. Hills | Director |
Other biotechnology companies in Georgia that filed recently
- Opus Medical Therapies, LLC $485,089 · Sep 22, 2026
- Airway Therapeutics, Inc. $43.5 million · Sep 9, 2026
- FEMASYS INC $30 million · Aug 20, 2026
Every Form D from the week of Aug 18, 2014 · All recent filings in Georgia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what MedShape, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.